Fmr LLC Aclaris Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 689,353 shares of ACRS stock, worth $813,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares

689,353

Previous 671,828 2.61%

Holding current value

$813,436

Previous $833,000 9.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.01 - $1.36 $17,700 - $23,834	17,525 Added 2.61%	689,353 $758,000
Q1 2024 May 13, 2024	BUY	$0.92 - $1.44 $1,024 - $1,604	1,114 Added 0.17%	671,828 $833,000
Q4 2023 Feb 13, 2024	BUY	$0.64 - $6.49 $6,024 - $61,096	9,414 Added 1.42%	670,714 $704,000
Q3 2023 Nov 13, 2023	SELL	$6.56 - $10.95 $569,178 - $950,076	-86,765 Reduced 11.6%	661,300 $4.53 Million
Q2 2023 Aug 11, 2023	SELL	$7.89 - $10.64 $39,260 - $52,944	-4,976 Reduced 0.66%	748,065 $7.76 Million
Q1 2023 May 11, 2023	SELL	$7.07 - $17.95 $137,405 - $348,858	-19,435 Reduced 2.52%	753,041 $6.09 Million
Q4 2022 Feb 13, 2023	SELL	$14.33 - $18.37 $5.34 Million - $6.85 Million	-372,863 Reduced 32.55%	772,476 $12.2 Million
Q3 2022 Nov 10, 2022	SELL	$13.07 - $18.22 $1.27 Million - $1.77 Million	-96,969 Reduced 7.81%	1,145,339 $18 Million
Q2 2022 Aug 12, 2022	BUY	$10.16 - $17.08 $294,213 - $494,602	28,958 Added 2.39%	1,242,308 $17.3 Million
Q1 2022 May 13, 2022	SELL	$9.74 - $17.92 $2.6 Million - $4.78 Million	-266,639 Reduced 18.02%	1,213,350 $20.9 Million
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $1.27 Million - $1.91 Million	-103,100 Reduced 6.51%	1,479,989 $21.5 Million
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $1.46 Million - $2.05 Million	-108,885 Reduced 6.44%	1,583,089 $28.5 Million
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $28.9 Million - $50.1 Million	1,691,974 New	1,691,974 $29.7 Million

Others Institutions Holding ACRS

# of Institutions

100

Shares Held

52.2M

Call Options Held

32.4K

Put Options Held

3.3K

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $78.7M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account